NEW YORK (GenomeWeb) – HTG Molecular this week disclosed in a filing with the US Securities and Exchange Commission that it has entered into a statement of work with Qiagen subsidiary Qiagen Manchester pursuant to a previously announced master assay development, commercialization, and manufacturing agreement.